Yendewa, G. A., Griffiss, J. M., Jacobs, M. R., Fulton, S. A., O'Riordan, M. A., Gray, W. A., Proskin, H. M., Winkle, P., & Salata, R. A. (2020). a two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation. Journal of global antimicrobial resistance, 21, 171–180. http://access.bl.uk/ark:/81055/vdc_100104357034.0x00000d